Morphosys extends technology agreement with Wacker
This article was originally published in Scrip
Executive Summary
MorphoSys and Wacker Biotech, a contract manufacturer of biopharmaceuticals derived from microbial systems, have extended their collaboration to use the latter company's bacterial secretion technology ESETEC.